Correlation Between Caribou Biosciences and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Mink Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Mink Therapeutics.
Diversification Opportunities for Caribou Biosciences and Mink Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Caribou and Mink is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Mink Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.96 times more return on investment than Mink Therapeutics. However, Caribou Biosciences is 1.04 times less risky than Mink Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 697.00 in Caribou Biosciences on September 26, 2024 and sell it today you would lose (528.00) from holding Caribou Biosciences or give up 75.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Mink Therapeutics
Performance |
Timeline |
Caribou Biosciences |
Mink Therapeutics |
Caribou Biosciences and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Mink Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Mink Therapeutics vs. Fate Therapeutics | Mink Therapeutics vs. Caribou Biosciences | Mink Therapeutics vs. Karyopharm Therapeutics | Mink Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |